The key in this Oncolix play is the Prolanta science..if it is real and it works, then all this bs is really bs...investors are not investing based on the financials but on the opportunity that Prolanta may bring..if Prolanta clinical trials are viewed as positive, then the money flow will be no problem as they will attract pharma partners and also possibly be acquired outright. So all this nonsense about no revenues and debt on the books is total bullshit or horseshit if you prefer..
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.